The role of two thioesterase genes in the premature release of polyketide synthase intermediates during rifamycin biosynthesis in the Amycolatopsis mediterranei S699 strain was investigated. Creation of an in-frame deletion in the rifR gene led to a 30-60% decrease in the production of both rifamycin B by the S699 strain or a series of tetra-to decaketide shunt products of polyketide chain assembly by the rifF strain. Since a similar percentage decrease was seen in both genetic backgrounds, we conclude that the Ri fR thioesterase 2 is not involved in premature release of the carbon chain assembly intermediates. Similarly, fusion of the Saccharopolyspora erythraea DEBS3thioesterase 1 domain to the C-terminus of the RifE PKS subunit did not result in a noticeable increase in the amountof the undecaketide intermediate formed nor in the amounts of the tetra-to decaketide shunt products. Hence, premature release of the carbon chain assembly intermediates is an unusual property of the Rif PKSitself.
Rifamycin B (1) is an ansamycin antibiotic produced by Amycolatopsis mediterranei and some of its derivatives are used clinically in the treatment of tuberculosis, leprosy and AIDS-related mycobacterial infections1>2). This antibiotic is made from 3-amino-5-hydroxybenzoic acid (AHBA2, Fig.  1 ) plus two acetate and eight propionate-derived units that are added to AHBA by a modular polyketide synthase (PKS) to form proansamycin X (3), followed by various largely oxidative steps that result in rifamycin S, which is converted to rifamycin SV and then to 1 ( Fig. 1)3 ). Chemical conversion of 1 to rifamycin SV followed by electrophilic substitution of the C-3 position has been used to make the important antibacterial drugs like rifampicin (rifampin) ( Fig. 1 ) and rifapentine as well as numerous other derivatives2'4'5^Despite extensive structure activity studies of the rifamycins, as recently summarized by Bacchi et al.6\ analogs with greatly improved utility over the current drugs have not been reported.
pp. 484 -495 Our interest in applying the methods of combinatorial biosynthesis to the quest for better rifamycin-derived drugs led us to clone and characterize the gene cluster from A. mediterranei strain S699 that is responsible for the production of 17'8). This consists of approximately 40 genes that include five PKS genes, which were cloned and characterized independently by Schupp et al.9\ The rifamycin PKS, composed of the Ri fA to RifE subunits, is responsible for the processive assembly of an undecaketide product ( Fig. 2) , which unlike typical macrolide PKSs10), is released from RifE and cyclized by the product of rifF acting as an amide synthase to form the ansamycin ring in proansamycin X (Fig. 2)1 1>12) . The A. mediterranei S699 wild-type and rifF mutant strains produce a series of acyclic polyketides ranging from tetra-to undecaketides (Fig. 2) Rifamycin B (1) is oxidized back to rifamycin S and Sy then the latter compound is converted to the antibacterial drug rifampicin by formylation followed by imine formation.
suggested that the naphthoquinones 4-10 are shunt products arising by spontaneous dehydration of the various 8-hydroxydihydronaphthoquinone ketide intermediates1 1}
because the carboxyl oxygen of AHBA is retained during its incorporation into 11U3). Furthermore, wen) and others14) have been unable to observe the incorporation of the 8-deoxy metabolite, protorifamycin I (ll, Fig. 2 ), into 1. Thus, both protorifamycin I and its precursor proansamycin B (Fig. 2 ) appear to be shunt products of the rifamycin pathway. The fact that the rifamycin PKS appears to shed its carbon chain assembly intermediates easily is unusual.
Macrolide producing bacteria are not knownto release the normal intermediates of polyketide chain assembly, except when one of the PKS genes has been mutated15'16), nor have such compounds been reported to be produced in vitro by the erythromycin PKS, 6-deoxyerythronolide B synthase (DEBS) (C. Khosla and R. McDaniel, personal communication) . Therefore, we wondered whether the premature release of the ketides shown in Fig. 2 is catalyzed by a specific enzyme or is just a special feature of the rifamycin PKS itself. One candidate for an accessory enzyme is the thioesterase 2-like protein encoded by the rifR (formerly, 0RF12) gene located approx. 23kb downstream of the rifA-rifF genes7). Here we report that inactivation of the rifR gene in both the S699 wild-type and rifF backgrounds did not cause a notable decrease in the shedding frequency of the rifamycin PKS, when compared with the behavior of the S699 and rifF strains. Similarly, fusion of the DEBS3 thioesterase 1 domain to the C-terminus of the RifE protein in a rifF mutant background did not favor formation of the undecaketide 4 nor alter the amounts of the other ketides produced.
Results
Mutation of the rifR Gene in the S699 Wild-type and rifF Backgrounds by Gene Replacement The rifR gene located between the 0RF13 and ORF20 to form the 8-hydroxy-7,8-dihydronaphthalene ring. Shunt products 4-10 may be formed by spontaneous dehydration to the 8-deoxynaphthoquinones followed by release from the PKS enzyme. Protorifamycin I (ll) and proansamycin B, putative precursors of 1, are shownin brackets.
(B) The structures of the 8-deoxynaphthoquinones isolated from the wild-type and the rifF and rifR strains. (B) The results of Southern-blot hybridization for the three strains used in this work. The two Apal fragments used for Southern analysis are shown above the physical mapof the genes. genes (Fig. 3A) of the A. mediterranei S699 and HGF019 rifF strains11} was replaced with a mutated version by gene replacement. This was accomplished as described in the Experimental section by removing the 345 bp ApalA segment between nts 2 and 346 of the ri/R ORF, which creates a 1 15 aa in-frame deletion in the Ri fR protein, and introducing the resulting suicide plasmid pWHM414 (Fig.   3A ) into the two strains by electroporation.
Hygromycin resistant transformants were transferred serially on solid media and the hygromycin sensitive clones isolated were screened by Southern analysis of their chromosomal DNA for ones that displayed the expected hybridization pattern (Fig. 3B ). From the six rifR and two rifF rifR mutants isolated, a representative rifR mutant (WMH1680) and a rifF rifR double mutant (WMH1681) were chosen for metabolite analysis. (1) and the shunt products shown in Fig. 2 by the A. mediterranei S699 wild-type, HGF019 rifF, WMH1680rifR and WMH1681rifF rifR mutants over a seven day period. Graphs B, Dand F show the average of the yields obtained with all six rifR and both rifF rifR mutants.
The graphs in C and D are the same as in A and B except that the range of the mMordinate has been decreased.
Production of Rifamycin B and Other Polyketides by the A. mediterranei rifR and rifF rifR Mutants
Whenthe metabolite profiles of the S699 and HGF019 rifFX X) strains were compared with those of the rifR mutant and the rifF rifR double mutant, as determined by HPLC analysis at 320nmof extracts of cultures grown in the YMGmedium used by Kim et al.ll\ much less rifamycin B was found to be produced by the S699 rifR mutant than by the S699 strain at the end of the fifth and sixth days of growth at the stationary phase ( Fig. 4A vs. 4B). The decrease in rifamycin B titer of the WMH1680 strain ranged from 40 to 60% of the values recorded for the S699 strain. This was accompanied by a similar decrease (40 to 60%) in the yield of the shunt metabolites arising from the polyketide chain assembly intermediates ( Fig. 4C vs. 4D). The WMH1681rifF rifR double mutant, which does not make 1, also produced a decreased amount of these intermediates ( Fig. 4F) , and the percentage decrease (30 to 60%) compared with the amounts recorded for the rifF strain ( Fig. 4E ) was similar to that observed when the rifR gene was inactivated in the S699 strain. Since the in-frame mutation in the rifR gene avoids the possibility of a polar effect on expression of the ORF20and ORF19 genes downstream of it (Fig. 3A) , we did not determine the metabolite profiles of the WMH1680or WMH1681 strains after introduction of the wild-type rifR gene. The ORF19 and ORF20 genes are predicted to encode, respectively, proteins similar to the Rhodococcus globerulus HppA 3-(3-hydroxyphenyl)-propionate hydro- Wewere concerned that the S699 strain and the rifF and rifR mutants derived from it might be accumulating the shunt metabolites shown in Fig. 2 as a result of some mutation introduced into the S699 strain during yield improvement work carried out at Lepetit laboratories.
Therefore, we obtained a culture of the original wild-type A. mediterranei ATCC13689 strain from this company's successor (Biosearch Italia, S.p.a.) and determined the yields of 1 and the shunt metabolites. Although these yields were considerably lower than those typically obtained with the S699 strain, both 1 and many of the shunt metabolites arising from the polyketide chain assembly intermediates were still produced (Fig. 5 ).
Production of Polyketides by an A mediterranei
HjEw TE rifF Mutant A notable advance in PKS biochemistry was the discovery of the functional independence of upstream modules in a modular PKSfrom downstream ones, first discovered upon expression of the eryAl gene encoding the DEBS1 protein18).
Placement of the thioesterase (TE) domain from module 6 ofDEBS3at the end of module 2 in DEBSI increased the level of production of the polyketide product considerably18~20). Subsequent studies of chimeric DEBS::TE proteins have shown that the TE domain can act on a wide range of chain lengths among the natural acylthioester intermediates of carbon chain assembly. This domain can also hydrolyze artificial substrates of different chain lengths and functionality22~24), although it exhibits highest activity towards substrates whose stereochemistry and functionality are closest to those found at the alpha and beta positions of the natural acylthioester substrates23'24).
We investigated the behavior of the genetically engineered Rif PKS in which the DEBS3 TE domain was located immediately downstream of the ACP10domain of the RifE protein to address the following two questions. (1) Can placement of the TE at the end of RifE accelerate product release so that the linear undecaketide precursor of proansamyin X would become the major product, and perhaps also suppress the amounts of the smaller ketides To test these ideas, we fused the TE domain of the DEBS3PKS to the C-terminus of the chromosomal copy of the rifE gene. Since we could not predict whether the rate ofpolyketide release catalyzed by the TE domain would be competitive with the action of the RifF enzyme, wecreated the RifE::TE fusion in a rifF mutant backgound as follows. The RifE::TE fusion was engineered as shown in Figs. 6A and 6B (see Experimental section) to mirror the architecture of the DEBS3-TEinterdomain region and the partial overlap of the C-terminus of RifE with the Nterminus of RifF as closely as possible (Fig.  6A ).
Introduction of this construct into the S699 strain by electroporation followed by selection for hygromycin resistant transformants resulted in a class of transformants where homologous recombination had taken place between the 2.3 kb C-terminal portion of the rifE gene in pWHM419 and the chromosomal rifE gene, resulting in the WMH1757 strain (Fig. 6C) . Here, the intact rifA-rifE\\TE PKS, ArifF, ORF1and rifG genes are separated by vector DNAfrom the^/-terminally truncated rifE gene followed by rifF, 0RF1, etc., as found in the native n/gene cluster (Fig. 6C) . This organization was deduced from the results of Southern analysis of DNAisolated from the WMH1757strain (Fig.  7) . Since the rifA to rifF genes are thought to be cotranscribed, the intact copy of rifF should not be expressed in this recombinant but the rifA to rifEv.TE genes pWHM41 6 and pWHM4 1 8 were derived from these templates by PCRmutagenesis and subcloning as explained in the Experimental section. Plasmid pANT841 H is a pANT841 derivative containing the hygromycin resistance (hyg) gene from plasmid pXH10632) as a 1.7 kb EcoKV-Smal fragment and inserted at Ecl\36ll site ofpANT841. A three piece ligation of pWHM416and pWHM418with the Spel-Nsil fragment containing the DEBS3 TE gene into the Kpnl-Hindll sites ofpANT841Hgave pWHM419.
(C) The region of the rifgene cluster undergoing recombination with pWHM419 is shown at the top. Homology driven recombination by a single crossover between the two rifE regions, as indicated by the 'X', gives the WMH1757 hygromycin resistant rijEv.TE rifF strain. The 7.8 kb PshAI fragment shown in Fig. 7 is indicated by the line above the WMH1757genotype. Total DNAfrom the S699 and three rifEwTE rifF mutant strains was digested with PshAl, separated by electrophoresis in a 0.8% agarose gel, transferred to a nylon membrane, and probed with DEBS3TE DNA fragment as described above for the analysis of the rifF mutant. Molecularweight markers are shownon the right hand side.
should, to form the engineered Rif PKS. The genes governing AHBA biosynthesis lying downstream of the ORF1gene were also expected to be expressed, based on the behavior of strains with disrupted rifD and rifE PKS genes1 1}.
The metabolite profile of the WMH1757 strain, when cultured in the same way as the rifR and rifR rifF mutant strains, showed the presence of the same mixture oftetra-to decaketide shunt products as in the latter two strains (data not shown). Preferential formation of the undecaketide nor any of the other, smaller ketides was not observed. Wedid not compare the relative amounts of the shunt products isolated from the WMH1757rifEv.TE rifF strain with those produced by the rifF or rifR rifF mutants.
Discussion
Many of the gene clusters that have been cloned from macrolide and nonribosomal peptide producing bacteria contain homologous genes for thioesterase 2-like proteins. In the case of pikromycin25) and tylosin26), inactivation of these genes resulted in a major decrease in antibiotic yield. Similar results have been reported for a strain that makes the non-ribosomal peptide antibiotic, surfactin27 prematurely, we investigated whether this is catalyzed by a specific enzyme. Athough these are normal intermediates while attached to the PKS in their 8-hydroxydihydronaphthoquinone forms, if spontaneous dehydration were to occur while they are still attached to the PKSenzymes, the resulting 8-deoxynaphthoquinones might block further extension of the carbon chain. The Ri fR protein might catalyze the release of such intermediates since it is a memberof the thioesterase 2 like protein family. If this were so, then we expected to see a large decrease in the amounts of these shunt products accumulated by the S699 and rifF strains when the rifR gene is inactivated. However, this is not the case since the rifR mutation caused about the same percentage decrease in the titer of both 1 and the shunt products in the wild-type background and of the shunt products in the rifF genetic background. As has been seen for the other antibiotics noted above, the rifR mutant produced considerably less rifamycin B and thus lack of the Ri fR protein clearly has a negative effect on some step of antibiotic biosynthesis. This step must be associated with VOL.53 NO.5 THE JOURNAL OF ANTIBIOTICS the polyketide assembly process, since the yields of the PKSshunt products were decreased as muchas that of 1.
Although the available information does not allow us to deduce the exact role of Ri fR, an editing activity is the most reasonable function and lack of this would tie up a certain fraction of the PKSenzymes to result in a lowered overall yield of their product(s).
In contrast, the expectation that the addition of the DEBS3 TE domain to the C-terminal end of the RifE PKS subunit would result in enhanced production of the undecaketide precursor of proansamycin X, or less likely, one or more of the ketide intermediates accumulated by the S699 and rifF mutants, was not borne out by our results. Hence, it appears that the substrate recognition properties of the RifE::TE enzyme are not broad enough to encompass the proximal region of the undecaketide intermediate, even
though the basic properties of the novel Rif PKS were maintained, as reflected in the formation of the tetra-to decaketide shunt products.
Together, these two sets of results show that premature release of its carbon chain assembly intermediates is an unusual property of the Rif PKS itself.
Experimental Bacterial Strains and Plasmids
The A. mediterranei S699 strain was obtained from Giangarlo Lancini at the former Lepetit laboratories, Geranzano, Italy, and the ATCC 13689 strain from Stefano Donadio at Biosearch S.p.a, Italy. E. coli strain DH5a29) wasused for routine subcloning. Plasmid pANT841 was obtained from W. R. Strohl, Ohio State University.
Media, Growth Conditions, and Fermentations A. mediterranei strains were maintained on YMG agar and grown in YMGliquid medium17) for preparation of protoplasts and seed inoculum for fermentations. Seed inoculum was also grown in YMG medium. A. mediterranei transformants were selected with hygromycin at 100/zg/ml in solid medium and 100/ig/ml in liquid medium. E. coli strains were grown in LB medium29ŝ upplemented with ampicillin (lOO^ag/ml), apramycin (25 jUg/ml) or tetracycline (15jiglvaX) for the selection of plasmids.
General DNAManipulations
DNAisolation, restriction and ligation were performed according to standard techniques29).
Qiaex resin (Qiagen, Chatsworth, CA) was used routinely to purify DNA 493 fragments from gel slices. Southern analysis of genomic DNAfrom the A. mediterranei strains was performed by standard methods29'30) using the Apal segment of the rifR gene as the probe DNA after labeing it with the digoxigenin-dUTP DNA labeling and detection kit from Boehringer, Mannheim, Germany.
Mutation of the A. mediterranei S699 rifR Gene The rifR gene was replaced by first creating the suicide plasmid pWHM414by insertion of the 2,7 kb Sphl-ApalA DNAsegment from 0RF13 and the 3.2kb ApalA-Nhel DNAsegment from rifR and ORF20 (Fig. 3) , cloned from pFKN108-E2 (T.-W. Yu & H.G.F, unpublished) , into the Sphl-Nhel site of pANT841, a pUC18 derivative that also carries a 1.7kb hygromycin resistance gene inserted in its Smal site11}. This resulted in pWHM414 carrying a 345 bp in-frame deletion at the TV-terminal end of the rifR ORE (Fig. 3B) .
Construction of the A. mediterranei S699 rifEv.TE rifF
Mutant Strain
To construct pWHM419 (Fig. 6B ), Spel and Nsil sites were introduced at the C-terminal ends of rifE and rifF as follows. Pairs of oligonucleotide primers were designed for PCRsubcloning for the two regions of DNAthat flank rifF so that a Spel site could be introduced in the Clal-Spel fragment obtained from the rifE/rifF template (Fig. 6B) . The Clal-Xhol segment of the resulting Clal-Spel fragment (pWHM415)was replaced with the Kpnl-Xhol segment of the template to give pWHM416.The internal BsiWl-PfMl segment of the PCR fragment pWHM417 from the rift/ORFl/rifG template (Fig. 6B ) was also replaced with the same DNAfrom the template to give pWHM418. The DNAsequences of the remaining portions of pWHM416 and pWHM418were verified by DNAsequencing. The 848 bp Spel-Nsil fragment from plasmid pKAO98, containing the DEBS3 TE domain (Fig.  6A ), was cloned with pWHM416and pWHM418in a three-piece ligation to give pWHM419 (Fig. 6B) , in which the last 4 amino acids of the rifE ACP10domain and all but the final five amino acids of the rifF ORF are replaced with the DEBS3TE domain (Fig.  6A ).
The A. mediterranei HfEwTErifF mutant was constructed by introducing pWHM419into the S699 strain by transformation, isolating hygromycin resistant transformants, and analyzing their genomic DNAby Southern-blot hybridization as described above. Three independent transformants were analyzed and all contained the unique 7.8 kb PshAl fragment (Fig. 7) with the rifEv.TE and ArifF genes expected for the genomic arrangement of the WHM1757 strain shown in Fig. 6C .
Determination of the Metabolic Profile of the A. mediterranei S699 and ATCC13689 Strains and the riJR, rifF rijR and rifE: : TE HfF Mutants The S699 and rifmutant strains were cultured in 50 ml YMG(g/liter) (yeast extract, 4; malt extract, 10; glucose 4) in 250 ml baffled flasks with 4 g of 3mmdiameter glass beads for 3 days at 300 rpm and 30°C. A 100/d portion of this seed culture (OD600 0.5) was inoculated into 50ml
YMGmedium in 250 ml baffled Erlenmeyer flasks and the cultures were grown as before for 7 days. A 0.5 ml portion of the culture was removed, diluted to 10% with distilled water, and the OD600 checked from day 3 to 7. These culture samples were separated from mycelium by centrifugation at 14,000 rpm in an Eppendorf tube, then the mycelia were washed with 0.5 ml distilled water and dried in a vacuum oven at 40°C overnight prior to weighing. The culture broth remaining on day 5 and 6 was acidified with 10.//1 acetic acid and extracted once with 0.5ml ethyl acetate. The ethyl acetate solution was dried in vacuo at less than 40°C and the residue was dissolved in 50)A methanol. A-20 /xl portion of this methanol solution was analyzed by HPLC31) using a Nova-Pak C18 column (Waters, Milford, MA; 3.9X 150mm; 4jUm.particle size) at a flow rate of 1 ml/minute. The mobile phase consisted of a linear gradient from 0.1 m sodium acetate buffer, pH 4.5 (adjusted with acetic acid), to 100% methanol over 20 minutes, followed by 10minutes at 100% methanol and then immediate return to the initial conditions for a 5 minutes re-equilibration period. The eluent was monitored at 320nm with the 996 Photodiode Array Detector (Waters). All the calculations of metabolite concentrations and preparation of tables were performed using the Millennium Chromatography Manager (Waters). The calibrations for determining the amounts of tetraketides and penta-to decaketides, and 1 for each set of analyses were generated by comparison of the peak-area ratio using authentic compounds11} as reference standards.
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